TRAC Visiting Faculty Seminar

Thursday, May 18, 2023 | 12pm - 1pm ET
Modulation of matrix metalloproteinases to improve patient outcomes
Speaker: Catherine Ong, PhD, FAMS, FRCP 

Please join us for the weekly Tuberculosis Research Advancement Center (TRAC) Seminar Series from 12:00 – 1:00 PM ET in CRB-2, 1M.13 or via Zoom: | Add to Calendar

The TRAC MIAMI Core is pleased to host Dr. Ong for a special Visiting Faculty Seminar during the TRAC Seminar Series.

Dr Catherine ONG PhD FAMS FRCP 
Assistant Professor, Department of Medicine, Yong Loo Lin School of Medicine, NUS
Principal Investigator, Institute for Health Innovation & Technology (iHealthtech)
Principal Investigator and Primary Member, Infectious Diseases Translational Research Programme
Senior Consultant, Division of Infectious Diseases, National University Hospital
Visiting Consultant, Tuberculosis Control Unit

Dr Catherine W.M. ONG MBBS MRCP(UK) MMed (Int Med) PhD FAMS FRCP is an Assistant Professor with the Department of Medicine at the Yong Loo Lin School of Medicine, Principal Investigator in iHealthtech NUS, Senior Consultant with the Division of Infectious Diseases in the National University Hospital and Visiting Consultant at the Singapore Tuberculosis Control Unit with both research and clinical interests in Tuberculosis. She serves in international journal editorial boards; as Associate Editor of the leading European Respiratory Journal, and Deputy Editor of the flagship International Journal of Tuberculosis and Lung Diseases. Her other portfolios include: Secretary to the ESCMID Study Group for Mycobacterial Infections (ESGMYC) and Vice-President of the Society of Infectious Disease (Singapore) in service of national and international societies.

Catherine graduated in medicine from NUS and during Infectious Diseases specialist training completed a full-time PhD at Imperial College London funded by the National Medical Research Council (NMRC) on the competitive National Research Foundation – Ministry of Health Scholarship. Her laboratory focuses on Tuberculosis host-pathogen interactions and TB host-directed therapies in multi-national clinical trials. Her works are published in top journals such as the Lancet Infectious Diseases, ERJ and the Journal of Clinical Investigation. Work is funded by the NMRC, Institut-Merieux, National Centre for Infectious Diseases and NUS with grant income as sole-PI of over SGD $10 million. Her students and research staff have won multiple national/international-level awards.

On clinical aspects of TB, Catherine serves the Ministry of Health Singapore, and works with WHO Coordinating Centres and WHO itself. For her work in tuberculosis, she received multiple national and international accolades. They include a Presidential Award prize at the American Society for Leukocyte Biology 2011, Keystone Symposia Global Health Travel Award by Bill and Melinda Gates Foundation 2012, International Investigator Award by the Infectious Diseases Society of America 2013, NMRC Transition Award 2015, Institut Merieux-SIDS Young Investigator Award 2018 and NMRC Clinician Scientist Award 2018 with successful renewal in 2022.